Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06126809 · ClinicalTrials.gov registry record · NA

Causal Role of the Aperiodic Signal for Working Memory

A NA study of Executive Dysfunction, sponsored by Florida State University.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06126809 is a NA study of Executive Dysfunction that is actively recruiting participants, run by Florida State University. The registered enrollment target is 30 participants, below the 136-participant average among 17 other Executive Dysfunction trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06126809, a NA study of Executive Dysfunction, is actively recruiting participants, sponsored by Florida State University.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Working memory (WM) is the ability to hold relevant information in mind in the absence of sensory input. The capacity for WM is a foundation for cognitive control and higher cognitive function more broadly. Previous research demonstrated that during the delay period of WM tasks, oscillatory electrical activity in the prefrontal cortex in the theta-frequency band (4-8 Hz) increased in amplitude. However, other groups found that the slope of the aperiodic signal in the brain was positively correlated with individual differences in WM capacity. Since low-frequency power and a steeper slope of the aperiodic signal are confounded in many analyses, it is not clear whether the slope of the aperiodic signal or the amplitude of low-frequency oscillations underlie WM capacity. With many studies investigating the causal role of theta oscillations in WM, the purpose of this project is to investigate the role of the aperiodic signal in WM performance.

Conditions Studied

Executive Dysfunction

Interventions

  • DEVICE Steep-tRAS
  • DEVICE Flat-tRAS
  • DEVICE Sham-tRAS

Study Locations (1)

Florida

  • Florida State University - Tallahassee

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-03-25
Est. Completion 2026-12
Phase NA

Sponsor

Florida State University

219 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06126809

The ClinicalTrials.gov registry entry for NCT06126809 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 136-participant average among 17 other Executive Dysfunction trials with a reported enrollment target (78% lower). The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Executive Dysfunction appearing as the primary indexed condition, and to 3 interventions - of which Steep-tRAS is the first listed.

NCT06126809 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06126809 about?

NCT06126809 is a clinical study titled "Causal Role of the Aperiodic Signal for Working Memory". Working memory (WM) is the ability to hold relevant information in mind in the absence of sensory input. The capacity for WM is a foundation for cognitive control and higher cognitive function more broadly. Previous research demonstrated that during the delay period of WM tasks, oscillatory electric...

What is the current status of trial NCT06126809?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-03-25. Estimated completion is 2026-12.

What conditions does trial NCT06126809 study?

This clinical trial studies the following conditions: Executive Dysfunction.

What interventions are being tested in trial NCT06126809?

The interventions under investigation include: Steep-tRAS (DEVICE), Flat-tRAS (DEVICE), Sham-tRAS (DEVICE).

Who is sponsoring clinical trial NCT06126809?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06126809 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Executive Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Executive Dysfunction

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.